SCHEMBL6949017

SCHEMBL6949017

CCCC1=NN(c2ccc(S(=O)(=O)O)cc2)C(=O)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHMT2 P34897 1/20 0.54
GAA P10253 5/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
ALDH1A1 P00352 7/20 0.43
MAPT P10636 6/20 0.43
LMNA P02545 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CASP6 P55212 1/20 0.41
KDM4E B2RXH2 3/20 0.40
RECQL P46063 1/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
CA12 O43570 1/20 0.40
KAT8 Q9H7Z6 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516786 0.90 SHMT2 (0.49) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL6474023 0.90 SHMT2 (0.49) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL8423717 0.85 GAA (0.43) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL6951753 0.85 SHMT2 (0.52) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL13597544 0.83 SHMT2 (0.46) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL5976250 0.83 SHMT2 (0.62) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL6948640 0.81 SHMT2 (0.48) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL5976498 0.80 SHMT2 (0.59) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL5975717 0.80 SHMT2 (0.59) SHMT2GAAKMT2AMEN1ALDH1A1
SCHEMBL5975777 0.80 KMT2A (0.60) SHMT2GAAKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed